Tim Van Hauwermeiren is one of Europe’s most successful biotech entrepreneurs, having turned a €1 million investment crisis into a drug company worth more than $28 billion today.
READ MOREVerona Pharma has secured up to $650 million to aid the potential launch of its COPD candidate ensifentrine.
READ MOREPhathom Pharmaceuticals is digesting news of an expanded label for its heartburn drug Voquezna.
READ MOREWelcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
READ MORE